DAXOR CORP — Director's Dealing 2025

Oct 2, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DAXOR CORP (DXR)
CIK: 0000027367
Period of Report: 2025-09-30

Reporting Person: Jefferies John (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Daxor Common Stock	15272	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$11.3	2028-04-30	Common Stock (885)		Direct
Stock Options (right to buy)	$9.55	2027-12-01	Common Stock (14660)		Direct
Stock Options (right to buy)	$9.51	2027-11-30	Common Stock (539)		Direct
Stock Options (right to buy)	$13.25	2027-10-31	Common Stock (283)		Direct
Stock Options (right to buy)	$13.25	2027-09-30	Common Stock (236)		Direct
Stock Options (right to buy)	$13.74	2027-08-31	Common Stock (309)		Direct
Stock Options (right to buy)	$13.96	2027-07-31	Common Stock (448)		Direct
Stock Options (right to buy)	$13.2	2027-06-30	Common Stock (284)		Direct
Stock Options (right to buy)	$12.63	2027-05-31	Common Stock (406)		Direct
Stock Options (right to buy)	$11.48	2027-04-30	Common Stock (327)		Direct
Stock Options (right to buy)	$10.65	2027-03-31	Common Stock (364)		Direct
Stock Options (right to buy)	$10.65	2027-02-28	Common Stock (469)		Direct
Stock Options (right to buy)	$10.53	2027-01-31	Common Stock (380)		Direct
Stock Options (right to buy)	$11.29	2026-12-31	Common Stock (199)		Direct
Stock Options (right to buy)	$11	2026-11-30	Common Stock (216)		Direct
Stock Options (right to buy)	$10.81	2026-10-31	Common Stock (116)		Direct
Stock Options (right to buy)	$11.68	2026-09-30	Common Stock (353)		Direct
Stock Options (right to buy)	$9.6	2026-08-31	Common Stock (221)		Direct
Stock Options (right to buy)	$9.09	2026-07-31	Common Stock (275)		Direct
Stock Options (right to buy)	$10.6	2026-06-30	Common Stock (224)		Direct
Stock Options (right to buy)	$9.35	2026-05-31	Common Stock (147)		Direct
Stock Options (right to buy)	$9.72	2026-04-30	Common Stock (129)		Direct
Stock Options (right to buy)	$12.1	2026-03-31	Common Stock (145)		Direct

Footnotes

F1: This option is presently exercisable in full.

F2: The stock options will vest in three equal installments on December 1, 2023, December 1, 2024 and December 1, 2025.